At 3 months, semaglutide typically produces 6 to 8% weight loss while tirzepatide produces 7 to 10%
These reports may reflect: Improved diabetes control : Better glycaemic management reduces osmotic diuresis (excessive urination due to glucose in urine), which might paradoxically make patients more aware of normal urination patterns if they were previously experiencing polyuria due to uncontrolled hyperglycaemia
It is an investigational research peptide and should not be confused with Sermorelin, which was historically FDA-approved for pediatric GH deficiency
NAD+ as a mood buster and to improve cognitive function NAD+ supports neurotransmitter function and improved cellular communication, making it a great option for improving clarity, focus, and emotional balance
It remains unclear however, whether this is due to weight loss or other effects of the drugs
BPC-157 may reduce pain perception for some users, but it should not be relied upon as primary pain management
,aspect=ignore)
